Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
Description
* To estimate the 2-year local control rate for adjuvant hypofractionated RT to the primary tumor bed.
* To estimate the 2-year nodal control rate for adjuvant hypofractionated RT to the primary draining nodal basin.
Secondary Objectives
* To determine MCC disease outcomes including:time to non-nodal locoregional recurrence, time to nodal recurrence, time to distant mestasis, disease-free-survival and disease-specific survival for patients receiving hypofractionated adjuvant RT.
* To assess acute and late RT associated toxicity within or neighboring the radiated field.
Our expert team has 10+ years running successful recruitment campaigns for clinical research sites